Diabetic Macular Edema
📧 Sign up to get email alerts when something new happens for Diabetic Macular Edema.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-08-12FDA Approved: EYLEA — Supplemental Application (Regeneron Pharmaceuticals, Inc.)
The FDA approved Regeneron's supplemental application for EYLEA (aflibercept), updating its labeling to reflect an expanded or modified indi…
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME) [Phase 2]
Phase 2 trial assessing the combination of THR-317 and Ranibizumab for diabetic macular edema has completed.
-
CLINICAL_TRIALS research · 2019-07-05Clinical Trial Update: Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema [Phase 4]
A Phase 4 clinical trial evaluating aflibercept with and without micropulse laser in diabetic macular edema has been completed.
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections [NA]
A completed clinical trial evaluating topical proparacaine eye drops to improve patient experience during intravitreal injections for age-re…
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME [Phase 3]
A Phase 3 trial comparing safety and efficacy of a labeled versus wait-extend regimen of Lucentis in Turkish patients with vision impairment…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab [Phase 1, Phase 2]
Phase 1 and 2 trial evaluating ranibizumab for diabetic macular edema in Chinese patients, focusing on visual outcomes and predictive factor…
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye [Phase 3]
Phase 3 trial update evaluating bloodstream absorption of Avastin and Lucentis after intravitreal injection in diabetic macular edema.
-
CLINICAL_TRIALS trial_result · 2019-05-22Clinical Trial Update: Alzer® and Diamel® to Prevent Severe Diabetes Macular Edema [Phase 2]
Phase 2 clinical trial update evaluating Alzer and Diamel to prevent severe diabetic macular edema.
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Safety and Effectiveness of Ozurdex Steroid Implants for DME After Vitrectomy Surgery [NA]
Clinical trial update on the safety and effectiveness of Ozurdex implants for diabetic macular edema after vitrectomy, terminated with resul…
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: IAI for Persistent DME After Treatment With Bevacizumab And Ranibizumab [Phase 4]
Phase 4 trial update on intravitreal anti-angiogenic inhibitor (IAI) for persistent diabetic macular edema after bevacizumab and ranibizumab…
-
CLINICAL_TRIALS trial_result · 2019-04-26Clinical Trial Update: Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs Aflibercept in Patients With DME [Phase 2]
Phase 2 trial comparing inflammation and pain after injection of ranibizumab versus aflibercept in diabetic macular edema has completed with…
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Diabetic Macular Edema Asian Response (DEAR) Study: Biomarkers for Response to Aflibercept in Asian Patients With Center Involving DME [Phase 4]
A Phase 4 trial evaluating biomarkers for response to aflibercept in Asian patients with diabetic macular edema.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Post Intravitreal Injection Topical NSAID vs. Patching [Phase 4]
A Phase 4 trial update comparing post-intravitreal injection topical NSAID versus patching for neovascular age-related macular degeneration …
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular Edema [Phase 4]
Phase 4 trial update reporting long-term efficacy and safety of aflibercept intravitreal injections for clinically significant diabetic macu…
-
CLINICAL_TRIALS trial_result · 2019-03-20Clinical Trial Update: Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema [Phase 2]
Phase 2 clinical trial assessing safety and effect on central retinal thickness of BI 1026706 in patients with diabetic macular edema; compl…
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study) [Phase 4]
Phase 4 trial update on a treat-and-extend regimen of aflibercept for diabetic macular edema ( VIBIM study ).
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema. [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of Lucentis (ranibizumab) in Chilean patients with diabetic macular edema has comp…
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema [Phase 4]
Phase 4 clinical trial evaluating the dexamethasone intravitreal implant for persistent diabetic macular edema has completed and results wer…
-
CLINICAL_TRIALS research · 2019-02-15Clinical Trial Update: To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.
A clinical trial update describing real-world use of intravitreal aflibercept and follow-up/treatment patterns for wet age-related macular d…
-
CLINICAL_TRIALS research · 2019-02-07Clinical Trial Update: Identifying Patients With Unrecognized Treatable Diabetic Macular Edema
This clinical trial update describes efforts to identify patients with previously unrecognized, treatable diabetic macular edema for potenti…
-
CLINICAL_TRIALS research · 2019-02-05Clinical Trial Update: The Effect of Intravitreal Erythropoietin Injection for Refractive Diabetic Macular Edema [Phase 2, Phase 3]
The document reports on a Phase 2/Phase 3 clinical trial evaluating intravitreal erythropoietin injections for refractory diabetic macular e…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: The Endurance 1 Trial [Phase 4]
The Endurance 1 Trial, a Phase 4 study for diabetic macular edema, has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients [Phase 3]
A Phase 3 randomized study comparing 0.5 mg ranibizumab to laser therapy in Chinese patients with diabetic macular edema completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study
The OZURDEX AUSSIEDEX trial evaluating the dexamethasone intravitreal implant (OZURDEX) for diabetic macular edema in Australia has complete…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Variable Interval Versus Set Interval Aflibercept for DME [Phase 4]
Phase 4 trial comparing variable interval vs set interval aflibercept for cystoid macular edema and diabetic macular edema has completed.